Robert Wong - Mar 6, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
VP, Chief Accounting Officer
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Wong
Stock symbol
CYTK
Transactions as of
Mar 6, 2023
Transactions value $
$0
Form type
4
Date filed
3/7/2023, 03:19 PM
Previous filing
Mar 3, 2023
Next filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +6K +27.76% $0.00 27.6K Mar 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (Right to Buy) Award $0 +2.46K $0.00 2.46K Mar 6, 2023 Common Stock 2.46K $39.13 Direct F2
transaction CYTK Non-Qualified Stock Option (Right to Buy) Award $0 +9.54K $0.00 9.54K Mar 6, 2023 Common Stock 9.54K $39.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2 This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.